Asra Kermani
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hormonal and reproductive studies
-
- Cardiovascular Function and Risk Factors
Papers in
-
- Peroxisome Proliferator-Activated Receptors 2
-
- Clinical practice guidelines implementation 2
- Co-authors
- Abhimanyu Garg (2 shared papers)Margo A. Denke (1 shared paper)Uģis Gruntmanis (1 shared paper)Beverley Adams‐Huet (1 shared paper)Sasan Mirfakhraee (1 shared paper)Michael E. Bowen (1 shared paper)Jaime P. Almandoz (1 shared paper)Carol J. McCall (1 shared paper)
- Journals
- Mayo Clinic Proceedings (2 papers)Journal of Investigative Medicine (1 paper)Diabetes (1 paper)Clinical Diabetes (1 paper)
- Partner nations
- United States
In The Last Decade
Asra Kermani
6 papers receiving 101 citations
Peers
Comparison fields: 5 of 44
- Endocrinology, Diabetes and Metabolism 60
- Cardiology and Cardiovascular Medicine 22
- Molecular Biology 64
- Biochemistry 6
- Pharmacology 13
Countries citing papers authored by Asra Kermani
This map shows the geographic impact of Asra Kermani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asra Kermani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asra Kermani more than expected).
Fields of papers citing papers by Asra Kermani
This network shows the impact of papers produced by Asra Kermani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asra Kermani. The network helps show where Asra Kermani may publish in the future.
Co-authors
The 10 scholars most cited alongside Asra Kermani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 92 | |
| 2 | 2007 | 6 | |
| 3 | 2020 | 3 | |
| 4 | EVALUATION THE EFFECT OF VITAMIN E ON PREMENSTRUAL SYNDROME | 2010 | 2 |
| 5 | 2023 | 1 | |
| 6 | 2004 | 1 |
About Asra Kermani
Asra Kermani is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, General Health Professions, Pulmonary and Respiratory Medicine and Oncology, having authored 6 papers that have together received 105 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (2 papers), Clinical practice guidelines implementation (2 papers), Healthcare Systems and Practices (1 paper), Hormonal and reproductive studies (1 paper), Bone health and osteoporosis research (1 paper), Bone health and treatments (1 paper), NF-κB Signaling Pathways (1 paper) and Chronic Disease Management Strategies (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (60 citations), Cardiology and Cardiovascular Medicine (22 citations), Molecular Biology (64 citations), Biochemistry (6 citations) and Pharmacology (13 citations). Asra Kermani has collaborated with scholars based in United States. Frequent co-authors include Abhimanyu Garg, Margo A. Denke, Uģis Gruntmanis, Beverley Adams‐Huet, Sasan Mirfakhraee, Michael E. Bowen, Jaime P. Almandoz, Carol J. McCall, David DeCaprio and Jason Fish. Their work appears in journals such as Mayo Clinic Proceedings, Journal of Investigative Medicine, Diabetes and Clinical Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.